GENERIC DRUGMAKER SANCTIONED AS JUDGE RULES DRUG INFRINGES SHIRE'S PATENTS

摘要

A federal judge ruled that a Florida-based generic drugmaker's version of extended-release Adderall infringed Shire PLC's patents and that it should be sanctioned for litigation misconduct. U.S. District Judge William Young in Boston said Abhai LLC showed an "appalling lack of awareness of a litigant's responsibility to our justice system" by not revealing until midway through a trial that it had discovered errors in its testing of the drug.